Approaches to estimate plasma kallikrein inhibition levels required for attack prophylaxis in hereditary angioedema

被引：0
|
作者：
Sexton, D. J. [1 ]
Faucette, R. [1 ]
Kenniston, J. [1 ]
Wang, Y. [1 ]
Rong, H. [1 ]
机构：
[1] Shire, Lexington, MA USA
来源：
ALLERGY | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1055
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [1] Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
    Banerji, A.
    Busse, P.
    Shennak, M.
    Lumry, W.
    Davis-Lorton, M.
    Wedner, H. J.
    Jacobs, J.
    Baker, J.
    Bernstein, J. A.
    Lockey, R.
    Li, H. H.
    Craig, T.
    Cicardi, M.
    Riedl, M.
    Al-Ghazawi, A.
    Soo, C.
    Iarrobino, R.
    Sexton, D. J.
    TenHoor, C.
    Kenniston, J. A.
    Faucette, R.
    Still, J. G.
    Kushner, H.
    Mensah, R.
    Stevens, C.
    Biedenkapp, J. C.
    Chyung, Y.
    Adelman, B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 717 - 728
  • [2] Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
    Aygoeren-Puersuen, E.
    Bygum, A.
    Grivcheva-Panovska, V.
    Magerl, M.
    Graff, J.
    Steiner, U. C.
    Fain, O.
    Huissoon, A.
    Kinaciyan, T.
    Farkas, H.
    Lleonart, R.
    Longhurst, H. J.
    Rae, W.
    Triggiani, M.
    Aberer, W.
    Cancian, M.
    Zanichelli, A.
    Smith, W. B.
    Baeza, M. L.
    Du-Thanh, A.
    Gompels, M.
    Gonzalez-Quevedo, T.
    Greve, J.
    Guilarte, M.
    Katelaris, C.
    Dobo, S.
    Cornpropst, M.
    Clemons, D.
    Fang, L.
    Collis, P.
    Sheridan, W.
    Maurer, M.
    Cicardi, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 352 - 362
  • [3] Kallikrein Inhibition for Hereditary Angioedema
    Longhurst, Hilary J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (08): : 788 - 789
  • [4] PLASMA KALLIKREIN AND PRORENIN IN PATIENTS WITH HEREDITARY ANGIOEDEMA
    PURDON, AD
    SCHAPIRA, M
    DEAGOSTINI, A
    COLMAN, RW
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1985, 105 (06): : 694 - 699
  • [5] Oral KVD900 provides rapid inhibition of plasma kallikrein and fast improvement in attack symptoms in patients with hereditary angioedema
    Smith, Michael D.
    Duckworth, Edward J.
    Hampton, Sally L.
    Yea, Christopher M.
    Audhya, Paul
    Feener, Edward P.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 563 - 563
  • [6] HEREDITARY ANGIOEDEMA ATTACK PROPHYLAXIS MANAGEMENT IN AUSTRALIAN PATIENTS
    Katelaris, C. H.
    Perram, F.
    Burton, P.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 27 - 27
  • [7] Ecallantide - Plasma kallikrein inhibitor, treatment of hereditary angioedema
    Revill, P.
    Mealy, N.
    [J]. DRUGS OF THE FUTURE, 2007, 32 (07) : 590 - 594
  • [8] Inhibitor of human plasma kallikrein DX-88 for the treatment of acute attack in a family with hereditary angioedema
    Anne, R
    Deveras, E
    Bracho, F
    [J]. BLOOD, 2004, 104 (11) : 113B - 114B
  • [9] FRESH FROZEN PLASMA FOR PROPHYLAXIS IN HEREDITARY ANGIOEDEMA
    JAFFE, CJ
    ATKINSON, JP
    GELFAND, JA
    FRANK, MM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1976, 57 (06) : 625 - 625
  • [10] Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
    Riedl, Marc
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2010, 3 : S34 - S38
12345